Disease | irritable bowel syndrome |
Symptom | C0401149|chronic constipation |
Sentences | 3 |
PubMedID- 20050846 | Tegaserod (teg), a 5-hydroxytryptamine type-4 (5-ht(4)) receptor partial agonist, represents a novel treatment for irritable bowel syndrome with constipation and chronic constipation. |
PubMedID- 20863829 | Linaclotide is a first-in-class, orally administered 14-amino acid peptide that is in development for the treatment of irritable bowel syndrome with constipation and chronic constipation. |
PubMedID- 21765950 | Tegaserod is an agonist of the serotonin receptor 5-hydroxytryptamine 4 (5-ht4) and has been used for treating chronic constipation in patients with irritable bowel syndrome and chronic idiopathic constipation , . |
Page: 1